CMIP (c-Maf inducing protein) is a multifunctional adapter protein with context-dependent roles in cell signaling and disease pathology. Primarily, CMIP participates in T-cell signaling, where it acts as a negative regulator by inhibiting Src kinases Fyn and Lck activation and blocking lipid raft recruitment after TCR engagement 1. However, CMIP exhibits distinct functions across different tissues and disease contexts. In metabolic tissues, CMIP protects cells from free fatty acid-induced lipotoxicity by modulating Akt signaling 2. During pregnancy, CMIP downregulation impairs trophoblast function via the PDE7B-cAMP pathway, contributing to preeclampsia development 3. In liver, CMIP regulates fatty acid metabolism through the Gbp2-PPARγ-CD36 axis, with altered DNA methylation of CMIP contributing to nonalcoholic fatty liver disease 4. In kidney disease, CMIP overexpression downregulates the podocyte protective factor WT1 through direct protein interaction and proteasome-mediated degradation, suggesting a pathogenic role in nephrotic syndrome 5. CMIP genetic variants (SNPs) associate with dyslipidemia and IgA nephropathy severity 6. Additionally, CMIP promotes glioma cell proliferation and metastasis via MDM2 upregulation, correlating with poor survival outcomes 7. Gene-diet interactions reveal that CMIP rs2925979 polymorphism modifies fruit intake's protective effect against type 2 diabetes 8.